Paul Jan Bröckelmann

28PUBLICATIONS
109CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesBiomechanicsHaematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 21, 2026
BrECADD in three days: Implementation of a condensed intensive first-line regimen in Hodgkin lymphoma.

|Apr 02, 2026
Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial.

Anne Sophie Robertz, Ina Bühnen, Julia Meissner

|Dec 24, 2025
Four Months of Exercise Intervention Improved Visuomotor, Functional and Cardiorespiratory Capacity in a Patient with Metastatic Uveal Melanoma.

Michael Mendes Wefelnberg, Stefanie Hennigfeld, Michael Simon

|Nov 01, 2025
Feasibility and safety of anti-PD1 first-line treatment of classic Hodgkin lymphoma: do we see the full picture?

Christian P Jaworek, Paul J Bröckelmann

|Jul 17, 2025
Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial.

Justin Ferdinandus, Helen Kaul, Alexander Fosså

|Apr 03, 2025
Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma.

Adrian Gottschlich, Ruth Grünmeier, Gordon Victor Hoffmann

Pageof 5

Frequent Collaborators

12 joint publications

Bastian von Tresckow

9 joint publications

Carsten Kobe

6 joint publications

Wolfram Klapper

5 joint publications

Dennis A Eichenauer